Open Versus Laparoscopic Versus Robotic Versus Transanal Mesorectal Excision for Rectal Cancer: A Systematic Review and Network Meta-analysis

Annals of Surgery

Volumn 270, Issue 1, 2019, Pages 59-68

  Simillis, Constantinos ^a,b   Lal, Nikhil ^a   Thoukididou, Sarah N ^a   Kontovounisios, Christos ^a,b   Smith, Jason J ^a,b   Hompes, Roel ^c   Adamina, Michel ^d   Tekkis, Paris P ^a,b  

^a CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

Author keywords

laparoscopic; mesorectal excision; network meta analysis; perioperative outcomes; rectal cancer; robotic; survival; systematic review; transanal

Indexed keywords

BAYES THEOREM; COMPARATIVE STUDY; HUMAN; LAPAROSCOPY; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM RESECTION; RECTUM TUMOR; ROBOTIC SURGICAL PROCEDURE; TRANSANAL ENDOSCOPIC SURGERY; TREATMENT OUTCOME;

BAYES THEOREM; HUMANS; LAPAROSCOPY; PROCTECTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; ROBOTIC SURGICAL PROCEDURES; TRANSANAL ENDOSCOPIC SURGERY; TREATMENT OUTCOME;

EID: 85064668728     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000003227     Document Type: Article

References (75)

1. International Agency for Research on Cancer, World Health Organisation. Cancer today. Cancer fact sheets. 2018. Available at: http://gco.iarc.fr/today. Accessed March 11, 2018.
2. Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718-1726.
3. Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637-645.
4. van der Pas MH, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14:210-218.
5. Bonjer HJ, Deijen CL, Abis GA, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N EnglJ Med. 2015;372:1324-1332.
6. Green BL, Marshall HC, Collinson F, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100:75-82.
7. Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopicassisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol. 2007;25:3061-3068.
8. Jayne DG, Thorpe HC, Copeland J, et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97:1638-1645.
9. Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for midrectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15:767-774.
10. Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015;314:1346-1355.
11. Stevenson AR, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314:1356-1363.
12. Ng KH, Lim YK, Ho KS, et al. Robotic-assisted surgery for low rectal dissection: from better views to better outcome. Singapore Med J. 2009;50:763-767.
13. Wexner SD, Bergamaschi R, Lacy A, et al. The current status of robotic pelvic surgery: results of a multinational interdisciplinary consensus conference. Surg Endosc. 2009;23:438-443.
14. Baik SH, Ko YT, Kang CM, et al. Robotic tumor-specific mesorectal excison of rectal cancer: short-term outcome of a pilot randomized trial. Surg Endosc. 2008;22:1601-1608.
15. Jayne D, Pigazzi A, Marshall H, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer the rolarr randomized clinical trial. JAMA. 2017;318:1569-1580.
16. Kim MJ, Park SC, Park JW, et al. Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial. Ann Surg. 2018;267:243-251.
17. Denost Q, Adam JP, Rullier A, et al. Perineal transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg. 2014;260:993-999.
18. Denost Q, Loughlin P, Chevalier R, et al. Transanal versus abdominal low rectal dissection for rectal cancer: long-term results of the Bordeaux' randomized trial. Surg Endosc. 2018;32:1486-1494.
19. Araujo SE, da Silva e Sousa AH Jr, de Campos FG, et al. Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Rev Hosp Clin Fac Med Sao Paulo. 2003;58:133-140.
20. Arteaga Gonzalez I, Diaz Luis H, Martin Malagon A, et al. A comparative clinical study of short-term results of laparoscopic surgery for rectal cancer during the learning curve. Int J Colorectal Dis. 2006;21:590-595.
21. Braga M, Frasson M, Vignali A, et al. Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Dis Colon Rectum. 2007;50:464- 471.
22. Fujii S, Ishibe A, Ota M, et al. Short-term results of a randomized study between laparoscopic and open surgery in elderly colorectal cancer patients. Surg Endosc. 2014;28:466-476.
23. Gong J, Shi DB, Li XX, et al. Short-term outcomes of laparoscopic total mesorectal excision compared to open surgery. World J Gastroenterol. 2012;18:7308-7313.
24. Ishibe A, OtaM, Fujii S, et al. Midterm follow-up of a randomized trial of open surgery versus laparoscopic surgery in elderly patients with colorectal cancer. Surg Endosc. 2017;31:3890-3897.
25. Kennedy RH, Francis EA, Wharton R, et al. Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL. J Clin Oncol. 2014;32:1804-1811.
26. King PM, Blazeby JM, Ewings P, et al. Randomized clinical trial comparing laparoscopic and open surgery for colorectal cancer within an enhanced recovery programme. Br J Surg. 2006;93:300-308.
27. Liang XB, Hou SH, Liu HY, et al. Effectiveness and safety of laparoscopic resection versus open surgery in patients with rectal cancer: a randomized, controlled trial from China. J Laparoendosc Adv Surg Tech. 2011;21:381-385.
28. Liu FL, Lin JJ, Ye F, et al. Hand-assisted laparoscopic surgery versus the open approach in curative resection of rectal cancer. J Int Med Res. 2010;38:916- 922.
29. Lujan J, Valero G, Hernandez Q, et al. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg. 2009;96:982-989.
30. Ng SS, Lee JF, Yiu RY, et al. Laparoscopic-assisted versus open total mesorectal excision with anal sphincter preservation for mid and low rectal cancer: a prospective, randomized trial. Surg Endosc. 2014;28:297-306.
31. Ng SS, Leung KL, Lee JF, et al. Long-term morbidity and oncologic outcomes of laparoscopic-assisted anterior resection for upper rectal cancer: ten-year results of a prospective, randomized trial. Dis Colon Rectum. 2009;52:558- 566.
32. Ng SS, Leung KL, Lee JF, et al. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial. Ann Surg Oncol. 2008;15:2418-2425.
33. Pan YF, Zhang XH, Jia XJ, et al. [Laparoscopic abdominoperineal resection for low rectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2007;10:253- 256.
34. Pechlivanides G, Gouvas N, Tsiaoussis J, et al. Lymph node clearance after total mesorectal excision for rectal cancer: laparoscopic versus open approach. Dig Dis. 2007;25:94-99.
35. Quah HM, Jayne DG, Eu KW, et al. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg. 2002;89:1551-1556.
36. Taylor GW, Jayne DG, Brown SR, et al. Adhesions and incisional hernias following laparoscopic versus open surgery for colorectal cancer in the CLASICC trial. Br J Surg. 2010;97:70-78.
37. Wang G,Wang Z, Jiang Z, et al. Male urinary and sexual function after robotic pelvic autonomic nerve-preserving surgery for rectal cancer. Int J Med Robotics Comput Assist Surg. 2017;13. e1725.
38. Xu J, Wei Y, Ren L, et al. Robot-assisted vs laparoscopic vs open abdominoperineal resections for low rectal cancer: short-term outcomes of a singlecenter prospective randomized controlled trial. Ann Oncol. 2017;28(supplement 5):v161-v162.
39. Zhang J, Luo C, Ji X, et al. Open total mesorectal excision for low rectal cancer: randomized controlled trial. Chin J Min Inv Surg. 2012;12:27-29.
40. Zhou ZG, Hu M, Li Y, et al. Laparoscopic vs open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc. 2004;18:1211-1215.
41. Breukink S, Pierie J, Wiggers T. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2006;CD005200.
42. Chen K, Cao G, Chen B, et al. Laparoscopic versus open surgery for rectal cancer: a meta-analysis of classic randomized controlled trials and highquality nonrandomized studies in the last 5 years. Int J Surg. 2017;39:1-10.
43. Ma B, Gao P, Song Y, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer. 2016;16:380.
44. Martinez-Perez A, Carra MC, Brunetti F, et al. Short-term clinical outcomes of laparoscopic vs open rectal excision for rectal cancer: a systematic review and meta-analysis. World J Gastroenterol. 2017;23:7906-7916.
45. Martinez-Perez A, Carra MC, Brunetti F, et al. Pathologic outcomes of laparoscopic vs open mesorectal excision for rectal cancer: a systematic review and meta-analysis. JAMA Surg. 2017;152:e165665.
46. Sun Y, Xu H, Li Z, et al. Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis. World J Surg Oncol. 2016;14:61.
47. Vennix S, Pelzers L, Bouvy N, et al. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2014;CD005200.
48. Wang Y, Zhao GH, Yang H, et al. A pooled analysis of robotic versus laparoscopic surgery for total mesorectal excision for rectal cancer. Surg Laparosc Endosc Percutan Tech. 2016;26:259-264.
49. Zhao JK, Chen NZ, Zheng JB, et al. Laparoscopic versus open surgery for rectal cancer: results of a systematic review and meta-analysis on clinical efficacy. Mol Clin Oncol. 2014;2:1097-1102.
50. Jansen JP, Naci H. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med. 2013;11:159.
51. Mills EJ, Ioannidis JP, Thorlund K, et al. How to use an article reporting a multiple treatment comparison meta-analysis. JAMA. 2012;308:1246-1253.
52. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9.
53. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187- 196.
54. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
55. Cochrane Methods Bias. Assessing risk of bias in included studies 2013. Available at: http://bmg.cochrane.org/assessing-risk-bias-included-studies. Accessed March 11, 2018.
56. Dias S, Welton NJ, Sutton AJ, et al. NICE DSU Technical Support Document 1: Introduction to evidence synthesis for decision making. 2012. Available at: http://www.nicedsu.org.uk. Accessed March 11, 2018.
57. Dias S, Sutton AJ, Welton NJ, et al. NICE DSU Technical Support Document 3: Heterogeneity: subgroups, meta-regression, bias and bias-adjustment. 2012. Available at: http://www.nicedsu.org.uk. Accessed March 11, 2018.
58. Dias S, Welton NJ, Sutton AJ, et al. NICE DSU Technical Support Document 2: A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials 2014. Available at: http://www.nicedsu.org.uk. Accessed March 11, 2018.
59. Dias S, Welton NJ, Sutton AJ, et al. NICE DSU Technical Support Document 4: Inconsistency in networks of evidence based on randomised controlled trials. 2012. Available at: http://www.nicedsu.org.uk. Accessed March 11, 2018.
60. Zheng J, Feng X, Yang Z, et al. The comprehensive therapeutic effects of rectal surgery are better in laparoscopy: a systematic review and meta-analysis. Oncotarget. 2017;8:12717-12729.
61. Garcia-Granero E, Faiz O, Munoz E, et al. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. Cancer. 2009;115:3400-3411.
62. Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828.
63. Rottoli M, Bona S, Rosati R, et al. Laparoscopic rectal resection for cancer: effects of conversion on short-term outcome and survival. Ann Surg Oncol. 2009;16:1279-1286.
64. Allemann P, Duvoisin C, Di Mare L, et al. Robotic-assisted surgery improves the quality of total mesorectal excision for rectal cancer compared to laparoscopy: results of a case-controlled analysis. World J Surg. 2016;40:1010-1016.
65. Egenvall M, Morner M, Pahlman L, et al. Degree of blood loss during surgery for rectal cancer: a population-based epidemiologic study of surgical complications and survival. Colorectal Dis. 2014;16:696-702.
66. Okamura R, Hida K, Hasegawa S, et al. Impact of intraoperative blood loss on morbidity and survival after radical surgery for colorectal cancer patients aged 80 years or older. Int J Colorectal Dis. 2016;31:327-334.
67. Vibert E, Perniceni T, Levard H, et al. Laparoscopic liver resection. Br J Surg. 2006;93:67-72.
68. Hompes R, Arnold S, Warusavitarne J. Towards the safe introduction of transanal total mesorectal excision: the role of a clinical registry. Colorectal Dis. 2014;16:498-501.
69. Sylla P, Bordeianou LG, Berger D, et al. A pilot study of natural orifice transanal endoscopic total mesorectal excision with laparoscopic assistance for rectal cancer. Surg Endosc. 2013;27:3396-3405.
70. Heald RJ. A new solution to some old problems: transanal TME. Tech Coloproctol. 2013;17:257-258.
71. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235:449-457.
72. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.
73. Rouanet P, Mourregot A, Azar CC, et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum. 2013;56:408-415.
74. Simillis C, Hompes R, Penna M, et al. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis. 2016;18:19-36.
75. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ. 2013;346:f2914.